SecProbe.io

CORRESP
1
filename1.htm

Meiwu
Technology Company Limited

1602,
Building C, Shenye Century Industrial Center

No.
743 Zhoushi Road, Hangcheng Street,

Bao’an
District

Shenzhen,
People’s Republic of China

February
28, 2024

VIA
EMAIL

U.S.
Securities and Exchange Commission

Division
of Corporation Finance

Office
of Trade & Services

100
F Street, N.E.

Washington,
DC 20549

    Attn:

    Robert
    Shapiro

    Lyn
    Shenk

    Re:
    Meiwu
    Technology Company Limited

    Amendment
    No. 2 to Form 20-F for Fiscal Year Ended December 31, 2022

    File
    No. 001-39803

Dear
Mr. Shapiro and Mr. Shenk:

Meiwu
Technology Company Limited (the “Company”, “WNW,” “Meiwu”, “we”,
“us” or “our”) hereby transmits its response to the letter received from the staff (the “Staff”)
of the Securities and Exchange Commission (the “Commission”), dated January 29, 2024 regarding our Form 20-F, as amended,
for fiscal year ended December 31, 2022. For ease of reference, we have repeated the Commission’s comments in this response and
numbered them accordingly.

Amendment
No. 2 to Form 20-F

Item
3. Key Information

Our
Corporate Structure, page 3

1. We
                                            note the structure charts you added in response to comment 4. Please provide your proposed
                                            revised disclosure that adds a footnote to disclose the 40% ownership of Heme Yulin.

Response:
In response to the Staff’s comment, please find below the proposed revision to include a footnote that explicitly details
the 40% ownership of Heme Yulin.

*

(1)
The 49% equity interests of Wude Shanghai are owned by Shenzhen Heme Enterprise Consulting Partnership (Limited Partnership), a limited
partnership organized under the laws of the PRC.

(2)
The 49% equity interests of Heme Brand are owned by Yafang Liu (25%) and Guoming Huang (24%).

(3)
The 30% equity interests of Jiayuan Liquo are owned by Kun Xu (21%) and Xi ‘an Senli Huinong Agricultural Technology Co. Ltd. (9%)

(4)
The 40% equity interests of Heme Yulin are owned by Taotao Shu.

Permission
or Approval Required from the PRC Authorities for the VIE’s Operations, page 9

2. We
                                            note your response and revised disclosure in response to prior comment 5. With respect to
                                            your PRC counsel, we note your revised disclosure “as confirmed by our PRC counsel,
                                            Dacheng ... .” If true, please provide your proposed revised disclosure that states
                                            that you relied on the “opinion” of counsel. Please make the same changes to
                                            your disclosure in response to prior comment 8 as well. Additionally, with respect to the
                                            uncertainty and consequences of any future actions of the PRC government, please provide
                                            your proposed revised disclosure to include the risk and related consequences if you do not
                                            receive or maintain such permissions or approvals. In this light, we point you to our original
                                            comment 8 in the comment letter dated August 11, 2023, to “ ... please revise to describe
                                            the consequences to you and your investors if you, your subsidiaries, or the VIEs: (i) do
                                            not receive or maintain such permissions or approvals, (ii) inadvertently conclude that such
                                            permissions or approvals are not required, or (iii) applicable laws, regulations, or interpretations
                                            change and you are required to obtain such permissions or approvals in the future.”
                                            (Emphasis added).

Response:
In response to the Staff’s comment, we proposed to revise the disclosure referencing our PRC counsel’s opinions as follows
(revised language in italic):

“Based
on the opinion of our PRC counsel, Beijing Dacheng Law Offices, LLP (Fuzhou) (“Dacheng”), …”

In
addition, we proposed to revise the disclosure relating to the consequences to us as follows (revised language in italic):

We
are subject to the risks of uncertainty of any future actions of the PRC government in this regard including the risk that we do not
receive or maintain such permissions or approvals, or we inadvertently conclude that the permission or approvals discussed here are
not required, that applicable laws, regulations or interpretations change such that we or the VIE, or any of its subsidiaries is required
to obtain approvals in the future, or that the PRC government could disallow our holding company structure, which would likely result
in a material change in our operations, including our ability to continue our existing holding company structure, carry on our current
business, accept foreign investments, and continue to offer securities to our investors. These adverse actions could cause the value
of our Ordinary Shares to significantly decline or become worthless. We may also be subject to penalties and sanctions imposed by the
PRC regulatory agencies, including the CSRC, if we fail to comply with such rules and regulations, which would likely adversely affect
the ability of our securities to be listed on the U.S. exchange, which would likely cause the value of our securities to significantly
decline or become worthless.

Selected
Condensed Consolidated Financial Schedule of Meiwu Technology Company Limited, its subsidiaries and the VIE, page 54

3. We
                                            note your revisions in response to comment 9. Please confirm that your annual report for
                                            the year ended December 31, 2023 will include similar revisions in your Consolidation of
                                            Variable Interest Entity disclosure in Note 3 to your financial statements.

Response:
In response to the Staff’s comment, we confirmed that our annual report for the year ended December 31, 2023 will include similar
revisions in the Consolidation of Variable Interest Entity disclosure in Note 3 to the financial statements.

Notes
to Consolidated Financial Statements

Note
12. Equity, page F-29

4. We
                                            note your response to comment 12. Please revise your disclosure of the $9.6 million of consideration
                                            to be delivered to the sellers in the Yuanxing acquisition on December 12, 2022 to reconcile
                                            with the $2,640,000 acquisition purchase price for the issuance of 12 million ordinary shares
                                            disclosed in Note 4.

Response:
In response to the Staff’s comment, we will revise our disclosure in the annual report for the year ended December 31, 2023
to reconcile $9.6 million of consideration to be delivered to the sellers in the Yuanxing acquisition on December 12, 2022 with the
$2,640,000 acquisition purchase price for the issuance of 12 million ordinary shares disclosed in Note 4.

We
appreciate the assistance the Staff has provided with its comments. If you have any questions, please do not hesitate to call our counsel,
Joan Wu, Esq. of Hunter Taubman Fischer & Li LLC, at (212) 530-2208.

    Sincerely,

    By:
    /s/
    Zihao Liu

    Zihao
                                            Liu

    Chief
    Financial Officer

    Meiwu
    Technology Company Limited

    cc:

    Joan
    Wu, Esq.

    Hunter
    Taubman Fischer & Li LLC